Status:
COMPLETED
Cardiovascular Patients With no Standard Modifiable Risk Factors
Lead Sponsor:
Jordan Collaborating Cardiology Group
Collaborating Sponsors:
The Jordan Cardiovascular Research Group JoCVRG
Yarmouk University School of Medicine
Conditions:
Cardiovascular Risk Factors
Eligibility:
All Genders
18+ years
Brief Summary
A growing number of patients develop atherosclerotic cardiovascular disease (ASCVD) despite the absence of standard modifiable risk factors (SMuRF-less). There is scarcity of studies that address this...
Detailed Description
Atherosclerotic coronary artery disease (ASCAD) claims millions of lives annually on a global level and is the leading cause of death in the Middle East. There are four standard modifiable cardiovascu...
Eligibility Criteria
Inclusion
- A diagnosis of atherosclerotic cardiovascular disease (ASCVD).
- Ability to fill the clinical form that evaluates the presence or absence of cardiovascular risk factors including the 4 SMuRFs.
Exclusion
- Atherosclerotic cardiovascular disease diagnosed before the age of 18 years.
- Inability to give detailed history of prespecified risk factors.
Key Trial Info
Start Date :
January 22 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2025
Estimated Enrollment :
5540 Patients enrolled
Trial Details
Trial ID
NCT06199869
Start Date
January 22 2024
End Date
January 31 2025
Last Update
February 25 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Istishari Hospital
Amman, Jordan, 11184
2
Yarmouk University School of Medicine
Irbid, Jordan